Difficulty: Medium
Average Score: 77%
Practice
Although reported to be less of a problem with Methimazole (Tapazole) than with Propylthiouracil (PTU), patients on antithyroid drug patients are at risk for the development of the adverse event of agranulocytosis. Understanding the pharmacotherapeutic and adverse effects, which of the following lab order sets would the advanced practice nurse routinely monitor for patients on Tapazole?
Correct answer
B
Rationale
The correct answer is B) TSH, free T4, and CBC with differential.
Tapazole (Methimazole) is associated with a lower risk of agranulocytosis compared to PTU. However, monitoring for this serious adverse effect is crucial in patients taking antithyroid drugs. A CBC with differential is essential to monitor for agranulocytosis, as it presents with a significant decrease in granulocytes.
Option A (CBC with differential) is not sufficient as it does not include thyroid function tests (TSH and free T4) which are essential in assessing the effectiveness of Tapazole therapy and thyroid function status.
Option C (TSH, free T4, and CBC) is close but lacks the crucial differential component of the CBC, which is necessary for detecting agranulocytosis.
Option D (CBC without differential) is inadequate as it does not provide the necessary information on specific cell counts that would indicate agranulocytosis.
Educationally, this question highlights the importance of comprehensive monitoring in pharmacotherapy. It emphasizes the need for a thorough understanding of drug-specific adverse effects and the appropriate laboratory tests required for monitoring. It also underscores the significance of considering both pharmacotherapeutic effects and potential adverse events in patient care.
Tapazole (Methimazole) is associated with a lower risk of agranulocytosis compared to PTU. However, monitoring for this serious adverse effect is crucial in patients taking antithyroid drugs. A CBC with differential is essential to monitor for agranulocytosis, as it presents with a significant decrease in granulocytes.
Option A (CBC with differential) is not sufficient as it does not include thyroid function tests (TSH and free T4) which are essential in assessing the effectiveness of Tapazole therapy and thyroid function status.
Option C (TSH, free T4, and CBC) is close but lacks the crucial differential component of the CBC, which is necessary for detecting agranulocytosis.
Option D (CBC without differential) is inadequate as it does not provide the necessary information on specific cell counts that would indicate agranulocytosis.
Educationally, this question highlights the importance of comprehensive monitoring in pharmacotherapy. It emphasizes the need for a thorough understanding of drug-specific adverse effects and the appropriate laboratory tests required for monitoring. It also underscores the significance of considering both pharmacotherapeutic effects and potential adverse events in patient care.